Glazer Capital LLC’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,309
Closed -$64K 261
2023
Q2
$64K Buy
+4,309
New +$152K ﹤0.01% 190

Glazer Capital LLC's ISEE Position: Q3 2023 in Review

Glazer Capital LLC sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 826,600 shares — an estimated $32.5M sold.

Glazer Capital LLC first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $32.5M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Glazer Capital LLC reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Glazer Capital LLC sold 826,600 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $32.5M.
  • Glazer Capital LLC first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Glazer Capital LLC's IVERIC bio, Inc. Common Stock position peaked at $32.5M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Glazer Capital LLC's 13F filing for Q3 2023, filed 14 Nov 2023.